| Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
| Nodes: 2913, Authors: 7350, Journals: 871, Outer References: 80285, Words: 5113
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by GCS. |
| # | Word | Pubs | TLCS | TGCS |
|---|---|---|---|---|
| 1 | PATIENTS | 176 | 711 | 6268 |
| 2 | TUBERCULOSIS | 356 | 1569 | 5642 |
| 3 | CLINICAL | 146 | 508 | 4442 |
| 4 | ACUTE | 89 | 489 | 4060 |
| 5 | HEALTH | 151 | 615 | 3621 |
| 6 | COST-EFFECTIVENESS | 91 | 524 | 3602 |
| 7 | MYOCARDIAL-INFARCTION | 53 | 526 | 3435 |
| 8 | RESEARCH | 67 | 117 | 3429 |
| 9 | REVIEW | 54 | 216 | 3428 |
| 10 | MEDICAL | 118 | 516 | 3018 |
| 11 | MYCOBACTERIUM | 159 | 567 | 2999 |
| 12 | BCG | 153 | 1073 | 2705 |
| 13 | RANDOMIZED | 27 | 94 | 2539 |
| 14 | EFFICACY | 68 | 1145 | 2528 |
| 15 | TRIALS | 36 | 66 | 2417 |
| 16 | USE | 100 | 150 | 2382 |
| 17 | LITERATURE | 30 | 712 | 2266 |
| 18 | DISEASE | 112 | 152 | 2235 |
| 19 | HIV | 144 | 228 | 2233 |
| 20 | METAANALYSIS | 23 | 557 | 2180 |
| 21 | ANALYSIS | 90 | 221 | 2174 |
| 22 | AIDS | 152 | 393 | 2155 |
| 23 | PAIN | 60 | 195 | 2139 |
| 24 | CHEST | 57 | 233 | 2103 |
| 25 | METHODS | 39 | 452 | 2056 |
| 26 | EMERGENCY | 33 | 192 | 2046 |
| 27 | CONTROLLED | 20 | 83 | 2030 |
| 28 | EVALUATION | 119 | 351 | 2017 |
| 29 | ECONOMIC | 30 | 129 | 2009 |
| 30 | RISK | 102 | 224 | 1978 |
| # | Word | Pubs | TLCS | TGCS |
| 31 | PREVENTION | 86 | 772 | 1870 |
| 32 | VACCINATION | 129 | 474 | 1856 |
| 33 | GUIDELINES | 25 | 81 | 1816 |
| 34 | TRIAL | 39 | 100 | 1813 |
| 35 | TREATMENT | 97 | 155 | 1810 |
| 36 | THERAPY | 52 | 121 | 1809 |
| 37 | DIAGNOSTIC | 71 | 300 | 1802 |
| 38 | VACCINE | 108 | 860 | 1765 |
| 39 | USING | 49 | 121 | 1763 |
| 40 | NEW | 93 | 178 | 1718 |
| 41 | TECHNOLOGY | 66 | 213 | 1699 |
| 42 | UTILITIES | 22 | 215 | 1688 |
| 43 | IMPLICATIONS | 47 | 300 | 1684 |
| 44 | PHYSICIANS | 37 | 80 | 1641 |
| 45 | TESTING | 68 | 106 | 1624 |
| 46 | PRACTICE | 37 | 56 | 1550 |
| 47 | META-ANALYSIS | 38 | 67 | 1531 |
| 48 | INFECTION | 98 | 210 | 1507 |
| 49 | CARE | 80 | 333 | 1480 |
| 50 | RESULTS | 43 | 96 | 1451 |
| 51 | BOVIS | 70 | 262 | 1445 |
| 52 | MEASUREMENT | 19 | 167 | 1409 |
| 53 | CARDIAC | 30 | 65 | 1399 |
| 54 | STATE | 22 | 115 | 1367 |
| 55 | HUMAN | 55 | 200 | 1348 |
| 56 | IMPACT | 71 | 190 | 1348 |
| 57 | EFFECT | 53 | 313 | 1293 |
| 58 | LIFE | 34 | 90 | 1280 |
| 59 | UTILIZATION | 23 | 63 | 1249 |
| 60 | CALMETTE-GUERIN | 62 | 327 | 1228 |
| # | Word | Pubs | TLCS | TGCS |
| 61 | VACCINES | 83 | 310 | 1207 |
| 62 | COST | 49 | 177 | 1181 |
| 63 | PREFERENCES | 25 | 311 | 1175 |
| 64 | MEDICINE | 39 | 71 | 1161 |
| 65 | ASSESSMENT | 62 | 323 | 1149 |
| 66 | QUALITY | 51 | 95 | 1093 |
| 67 | COMPARISON | 44 | 320 | 1073 |
| 68 | CHANGING | 15 | 60 | 1070 |
| 69 | BEHAVIOR | 23 | 82 | 1066 |
| 70 | IMMUNITY | 23 | 274 | 1033 |
| 71 | INTERVENTIONS | 16 | 45 | 1013 |
| 72 | PEPTIC-ULCER | 50 | 266 | 992 |
| 73 | TIME | 39 | 157 | 985 |
| 74 | STRATEGIES | 40 | 150 | 978 |
| 75 | ROOM | 8 | 73 | 977 |
| 76 | MULTICENTER | 9 | 84 | 974 |
| 77 | THROMBOLYTIC | 14 | 38 | 969 |
| 78 | QUANTITATIVE | 9 | 42 | 944 |
| 79 | RECOMMENDATIONS | 7 | 28 | 928 |
| 80 | HEALTH-CARE | 40 | 69 | 922 |
| 81 | PROTECTIVE | 36 | 273 | 910 |
| 82 | QUALITY-OF-LIFE | 17 | 96 | 904 |
| 83 | HOSPITAL | 38 | 74 | 899 |
| 84 | PATIENT | 42 | 55 | 899 |
| 85 | REPORT | 23 | 163 | 894 |
| 86 | DECISIONS | 25 | 40 | 891 |
| 87 | SCREENING | 48 | 165 | 888 |
| 88 | META-ANALYSES | 4 | 103 | 880 |
| 89 | APPRAISAL | 2 | 83 | 861 |
| 90 | TOMOGRAPHY | 36 | 415 | 855 |
| # | Word | Pubs | TLCS | TGCS |
| 91 | EARLY | 26 | 43 | 853 |
| 92 | UNITED-STATES | 18 | 231 | 834 |
| 93 | CURRENT | 29 | 58 | 830 |
| 94 | LABORATORY | 33 | 63 | 829 |
| 95 | ADOPTION | 6 | 25 | 824 |
| 96 | TRIAGE | 10 | 59 | 822 |
| 97 | OUTCOMES | 30 | 275 | 819 |
| 98 | PRACTICES | 18 | 118 | 819 |
| 99 | RAPID | 14 | 28 | 819 |
| 100 | DRUGS | 14 | 27 | 813 |
| 101 | EVIDENCE | 32 | 43 | 794 |
| 102 | EVALUATIONS | 9 | 39 | 772 |
| 103 | BACILLUS | 37 | 164 | 763 |
| 104 | COMPUTED-TOMOGRAPHY | 45 | 91 | 762 |
| 105 | PUBLISHED | 7 | 633 | 762 |
| 106 | IMMUNE | 43 | 118 | 761 |
| 107 | RESPONSES | 45 | 168 | 757 |
| 108 | MANAGEMENT | 46 | 60 | 753 |
| 109 | CONTROL | 52 | 112 | 741 |
| 110 | TRENDS | 24 | 197 | 723 |
| 111 | COMPUTED | 31 | 288 | 720 |
| 112 | ISSUES | 37 | 47 | 715 |
| 113 | UNIT | 27 | 131 | 713 |
| 114 | MEDICAL-CARE | 7 | 6 | 712 |
| 115 | TEST | 37 | 71 | 706 |
| 116 | BACILLE | 38 | 201 | 705 |
| 117 | IMAGING | 52 | 101 | 699 |
| 118 | IMPROVE | 12 | 4 | 697 |
| 119 | CHARACTERISTICS | 11 | 61 | 690 |
| 120 | EFFECTS | 40 | 63 | 690 |
| # | Word | Pubs | TLCS | TGCS |
| 121 | CHILDREN | 52 | 71 | 686 |
| 122 | PANEL | 3 | 19 | 684 |
| 123 | SYSTEMATIC | 9 | 6 | 678 |
| 124 | CELLS | 33 | 96 | 676 |
| 125 | PORCINE | 17 | 61 | 669 |
| 126 | ATTRACTIVE | 1 | 19 | 665 |
| 127 | TENTATIVE | 1 | 19 | 665 |
| 128 | WARRANT | 1 | 19 | 665 |
| 129 | COSTS | 26 | 147 | 663 |
| 130 | INTRODUCTION | 19 | 153 | 663 |
| 131 | STANDARDS | 5 | 26 | 659 |
| 132 | ROLE | 47 | 63 | 658 |
| 133 | UTILITY | 47 | 115 | 658 |
| 134 | DIAGNOSTIC-TESTS | 9 | 31 | 657 |
| 135 | CLINICAL-TRIALS | 11 | 73 | 656 |
| 136 | PRIMARY | 23 | 42 | 652 |
| 137 | DNA | 25 | 145 | 650 |
| 138 | CELL | 33 | 79 | 636 |
| 139 | ISCHEMIA | 12 | 56 | 636 |
| 140 | MEASURING | 20 | 92 | 633 |
| 141 | SATISFACTION | 4 | 3 | 632 |
| 142 | MODEL | 37 | 148 | 625 |
| 143 | ANTIGEN | 31 | 119 | 616 |
| 144 | DIAGNOSIS | 44 | 54 | 614 |
| 145 | CASE | 30 | 158 | 604 |
| 146 | DESIGNS | 2 | 12 | 594 |
| 147 | MAGIC | 3 | 27 | 593 |
| 148 | APPROACH | 25 | 39 | 592 |
| 149 | BULLETS | 2 | 27 | 589 |
| 150 | DIFFERENCES | 11 | 49 | 589 |
| # | Word | Pubs | TLCS | TGCS |
| 151 | MEANS | 5 | 20 | 589 |
| 152 | PROTOCOL | 7 | 65 | 587 |
| 153 | VARIATION | 10 | 137 | 586 |
| 154 | MOLECULAR | 12 | 82 | 585 |
| 155 | COMPLICATIONS | 6 | 24 | 583 |
| 156 | PROFESSIONAL | 4 | 5 | 583 |
| 157 | TECHNOLOGIES | 26 | 58 | 582 |
| 158 | EPIDEMIOLOGIC | 4 | 23 | 579 |
| 159 | RECOMBINANT | 33 | 132 | 575 |
| 160 | PROGRAM | 20 | 35 | 571 |
| 161 | PROTECTION | 31 | 157 | 570 |
| 162 | RUBELLA | 23 | 149 | 565 |
| 163 | TROPONIN | 4 | 8 | 561 |
| 164 | SEXUAL | 16 | 19 | 558 |
| 165 | EFFECTIVENESS | 21 | 51 | 556 |
| 166 | METHODOLOGICAL | 13 | 33 | 556 |
| 167 | IMMUNODEFICIENCY | 24 | 60 | 553 |
| 168 | IMMUNIZATION | 34 | 71 | 552 |
| 169 | HIERARCHY | 1 | 1 | 551 |
| 170 | OBSERVATIONAL | 1 | 1 | 551 |
| 171 | VALUE | 31 | 140 | 549 |
| 172 | ANTIINFLAMMATORY | 3 | 7 | 544 |
| 173 | VIRUS | 30 | 70 | 543 |
| 174 | PROGRESS | 16 | 73 | 541 |
| 175 | INTERVENTION | 21 | 21 | 536 |
| 176 | NONSTEROIDAL | 2 | 7 | 534 |
| 177 | EXPRESSING | 14 | 139 | 530 |
| 178 | PEPTIC-ULCERATION | 2 | 9 | 517 |
| 179 | ENDOGENOUS | 14 | 60 | 516 |
| 180 | PHYSICIAN | 14 | 42 | 513 |
| # | Word | Pubs | TLCS | TGCS |
| 181 | INFLUENCE | 22 | 82 | 511 |
| 182 | THREATENING | 2 | 7 | 509 |
| 183 | CANCER | 38 | 15 | 507 |
| 184 | OUTCOME | 17 | 64 | 503 |
| 185 | TESTS | 29 | 93 | 503 |
| 186 | ADMISSION | 19 | 205 | 502 |
| 187 | RISKS | 17 | 71 | 498 |
| 188 | DECISION-ANALYSIS | 14 | 60 | 496 |
| 189 | XENOTRANSPLANTATION | 65 | 155 | 494 |
| 190 | BASED | 19 | 29 | 490 |
| 191 | GENETIC | 9 | 44 | 490 |
| 192 | EVALUATING | 23 | 59 | 481 |
| 193 | CHRONIC | 18 | 67 | 480 |
| 194 | MORTALITY | 25 | 43 | 478 |
| 195 | WOMEN | 25 | 52 | 478 |
| 196 | NATIONAL | 22 | 42 | 477 |
| 197 | ACTIVATOR | 4 | 38 | 473 |
| 198 | SURGERY | 30 | 41 | 469 |
| 199 | DEVELOPMENT | 29 | 51 | 467 |
| 200 | DISEASES | 35 | 27 | 466 |
Page 1 of 26: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21